• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Eugia Pharma receives FDA approval for Pazopanib Tablets, 200 mg

    INDPHARMAPOST

    Eugia Pharma`s Generics Afatinib Receives Approval in US

    FDA

    Eugia Steriles receives EIR from US FDA

    EXPRESSPHARMA

    Eugia Steriles` New Injectables Facility Gets First FDA Product Approval

    ECONOMICTIMES

    Eugia Pharma on Health Canada Inspection List

    HEALTH CANADA

    USFDA pulls up Eugia for manufacturing lapses, data accuracy at Hyderabad plant

    ECONOMICTIMES

    Eugia Pharma Specialities Receives FDA Warning Letter

    FDA

    Aurobindo Pharma`s Eugia Unit-3 gets warning letter from USFDA, shares fall

    ECONOMICTIMES

    Aurobindo may take its injectable unit public

    ECONOMICTIMES

    Enforcement Report for Week of August 7, 2024

    FDA

    FDA Issues `Official Action Indicated` For Aurobindo`s Eugia Unit

    BSEINDIA

    Enforcement Report - Week of June 26, 2024

    FDA

    Eugia Pharma`s Generic Busulfan Receives Approval in US

    FDA

    Under FDA scrutiny, Aurobindo`s Eugia tallies a 5th Form 483 in less than a year

    FIERCE PHARMA

    FDA Issues Form 483 to Eugia Pharma Specialities

    FDA

    Enforcement Report - Week of April 17, 2024

    FDA

    FDA Issues Form 483 to Eugia Steriles Private Limited

    FDA

    Aurobindo arm gets 3 observations from US FDA after Andhra unit inspection

    MONEYCONTROL

    Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection Due to Presence of White Particles

    FDA

    Enforcement Report - Week of March 27, 2024

    FDA

    FDA Issues Form 483 to Eugia SEZ Private Limited

    FDA

    Eugia`s Generic Sunitinib Malate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of March 13, 2024

    FDA

    FDA Issues Form 483 to Eugia Pharma Specialities Limited

    FDA

    Empower Pharma to Purchase Eugia Manufacturing Facility in New Jersey

    PR NEWSWIRE

    Compounding pharmacy Empower buys Eugia facility in New Jersey

    FIERCE PHARMA

    FDA Issues Form 483 to Eugia US Manufacturing LLC

    FDA

    Eugia Pharma`s Generic Gentamicin Sulfate Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Sugammadex Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Neostigmine Methylsulfate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of October 11, 2023

    FDA

    Aurobindo Pharma gets U.S. FDA nod for generic Icatibant injection

    THE HINDU

    Eugia Pharma`s Generic Icatibant Acetate Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Etelcalcetide Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Vancomycin Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia`s Generic Bromfenac Receives Approval in the U.S.

    FDA

    Eugia`s Generic Fulvestrant Receives Approval in the U.S.

    FDA

    Eugia signs voluntary license with Medicines Patent Pool to develop Nilotinib

    INDIANPHARMAPOST

    Aurobindo arm signs pact with Medicines Patent Pool to develop anti-cancer drug

    ECONOMIC TIMES

    Eugia`s Generic (Tobramycin Sulfate) Receives Approval in the U.S.

    FDA

    Eugia`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia Pharma`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.

    FDA

    Eugia`s Generic Lenalidomide Receives Approval in the U.S.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.